Literature DB >> 16314776

Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001.

Madeline Y Sutton1, Maya Sternberg, Akbar Zaidi, Michael E St Louis, Lauri E Markowitz.   

Abstract

OBJECTIVE: The objective of this study was to describe the estimated trends in incidence of pelvic inflammatory disease (PID) among reproductive-aged women in hospital and ambulatory settings. STUDY: Analyses of PID estimates were performed. Three nationally representative surveys conducted by the National Center for Health Statistics (NCHS): National Hospital Discharge Survey (NHDS), National Hospital Ambulatory Medical Care Survey (NHAMCS), and National Ambulatory Medical Care Survey (NAMCS), were used to obtain the estimates of PID (defined by International Classification of Diseases, 9th Revision codes). National Disease and Therapeutic Index (NDTI) estimates were reviewed for comparison.
RESULTS: Rates of hospitalized PID declined 68% overall from 1985 through 2001 (P <0.0001). Ambulatory data support a decrease in PID from 1985 to 2001. From 1995 to 2001, approximately 769,859 cases of acute and unspecified PID were diagnosed annually, 91% in ambulatory settings.
CONCLUSIONS: PID has decreased in hospital and ambulatory settings. The expanded national surveys in outpatient and emergency departments provide more complete estimates for PID. Optimal management of PID should target ambulatory settings, where the majority of cases are diagnosed and treated.

Entities:  

Mesh:

Year:  2005        PMID: 16314776     DOI: 10.1097/01.olq.0000175375.60973.cb

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  39 in total

1.  Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management.

Authors:  Richard L Sweet
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

Review 2.  Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Authors:  Bahaa Abu Raya; Ellen Bamberger; Nogah C Kerem; Aharon Kessel; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

3.  Under-reporting of pelvic inflammatory disease in Hawaii: a comparison of state surveillance and hospitalization data.

Authors:  Misty Pacheco; Tetine Sentell; Alan R Katz
Journal:  J Community Health       Date:  2014-04

Review 4.  Pelvic inflammatory disease.

Authors:  Jonathan D C Ross
Journal:  BMJ Clin Evid       Date:  2013-12-11

5.  Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.

Authors:  Maria Trent; Debra Bass; Roberta B Ness; Catherine Haggerty
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

6.  Pelvic Inflammatory Disease in a Pediatric Emergency Department: Epidemiology and Treatment.

Authors:  Michelle Solomon; Lisa Tuchman; Katie Hayes; Gia Badolato; Monika K Goyal
Journal:  Pediatr Emerg Care       Date:  2019-06       Impact factor: 1.454

7.  Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive-aged women in the United States, 1995 and 2006-2010.

Authors:  Jami S Leichliter; Anjani Chandra; Sevgi O Aral
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

Review 8.  Pelvic inflammatory disease.

Authors:  Maria Trent
Journal:  Pediatr Rev       Date:  2013-04

Review 9.  Status of adolescent pelvic inflammatory disease management in the United States.

Authors:  Maria Trent
Journal:  Curr Opin Obstet Gynecol       Date:  2013-10       Impact factor: 1.927

Review 10.  Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.

Authors:  Christina B Rasmussen; Susanne K Kjaer; Vanna Albieri; Elisa V Bandera; Jennifer A Doherty; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Robert P Edwards; Joellen M Schildkraut; Andrew Berchuck; Sara H Olson; Lambertus A Kiemeney; Leon F A G Massuger; Steven A Narod; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Anna H Wu; Celeste L Pearce; Harvey A Risch; Allan Jensen
Journal:  Am J Epidemiol       Date:  2016-12-09       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.